Menu

Month: March 2025

News Alert

Utah House Unanimously Passes 340B Contract Pharmacy Access Bill, But Senate Pushes for Changes

William Newton, Associate Editor/Senior Writer Views
The Utah House voted, 73-0, to pass a 340B contract pharmacy access bill on March 4.
The Utah House earlier today unanimously passed a bill to block drugmakers from restricting 340B contract pharmacy access in the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Key Votes on 340B Contract Pharmacy Access Bills in Utah, New Mexico, Michigan; Bill Introductions in Kansas and Florida

William Newton, Associate Editor/Senior Writer Views
Utah Rep. Steve Eliason (R), who introduced a 340B contract pharmacy access bill, unexpectedly put forward a motion to reconsider his bill 40 minutes after it unanimously passed the state House on Feb. 28.
State lawmakers in Utah, New Mexico, Michigan, Kansas and Florida have all recently voted on or introduced bills to prohibit [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Florida Providers Concerned New State Medicaid Reimbursement Bill Could Significantly Restrict 340B Savings

William Newton and Bella Czajkowski, Associate Editor/Senior Writer Views
Some Florida providers are concerned about the 340B implications of a recently introduced state Medicaid reimbursement bill with ambiguous language.
Florida providers are concerned that a new state bill, which aims to lower Medicaid prices in the state, could significantly [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

AbbVie Adds 340B Restrictions to Cancer, Parkinson’s Treatment Drugs

Shannon Young, Associate Editor/Senior Writer Views
AbbVie announced that its contract pharmacy restrictions now apply to two new drugs: Elahere and Vyalev.
A Chicago-based drugmaker recently added two new medications to its growing list of drugs subject to 340B contract pharmacy restrictions.  [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Eli Lilly, Eisai, GSK and Merck Announce 340B Refunds, Other Drugmakers Report NDC Changes

Shannon Young, Associate Editor/Senior Writer Views
Several drugmakers notified covered entities of changes to their 340B drug ceiling prices and national drug codes in notices posted on the Health Resources and Services Administration’s website in January and February.
Several drugmakers recently notified covered entities of changes to their 340B drug ceiling prices, resulting in refunds, while others announced [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Expert Tip from SunRx

Sponsored Content Views
img
img

TIP: Take time to focus on these three important fundamentals of 340B program compliance and integrity.

Update

…
Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live